A maker of advanced engineered materials, Materion produces beryllium and specialty alloys, precision strip, chemicals, and precision optics for semiconductors, aerospace, defense, and automotive. It traces its roots to Brush Laboratories, founded in 1921 in Cleveland to extract beryllium, and took the name Materion in 2011. The company runs the world's largest bertrandite ore mine, and its beryllium — lighter than aluminum yet six times stiffer than steel — flew in the James Webb Space Telescope.
Value-added sales rose 15% and gross margin on those sales hit 34%, the highest level in over three years.
Materion's underlying business accelerated sharply. rose 15% to $308.2 million and on those sales reached 34%, driven by aerospace and defense volumes up 39% and semiconductor volumes up 23%. The company is growing its core processing business at a double-digit rate for the first time in years, but a $100 million plan and $423.2 million in debt raise the bar for cash generation.
Key takeaways
, which strip out pass-through metal costs to reflect the company's own processing activity, rose 15% to $308.2 million — the first double-digit growth in this measure in over three years, driven by a 39% increase in aerospace and defense volumes and a 23% increase in semiconductor volumes.
as a percentage of improved to 34% from 31% a year ago, the highest level since at least Q1 2022, as favorable product mix, manufacturing efficiencies, and higher beryllium hydroxide sales lifted profitability.
Section summaries
Management's Discussion and Analysis
Q2 FY2026 net sales rose 42% to $613.9M, driven by Electronic Materials and higher precious metal pass-through costs.
⌄
increased 42% to $613.9M, with $94.6M of the increase from higher precious metal pass-through costs in the Electronic Materials .
Total reported rose 42% to $613.9 million, but $94.6 million of the increase came from higher precious metal in the Electronic Materials , which inflate revenue without contributing to processing margin.
rose 40% to $51.7 million, and rose 54% to $38.8 million, or $1.84 per diluted share, as the expansion and volume growth flowed through to the bottom line.
for the first six months reached $70.5 million, up from $65.4 million a year ago, supported by management, with $232.7 million in available borrowing capacity at quarter-end.
The company expects full-year 2026 of approximately $100 million, up from the $70 million expected for 2025, signaling a step-up in investment that will require sustained cash generation to fund without increasing .
What changed
The Q1 FY2026 flag on growth accelerating from 1% has been resolved: growth rose to 15% in Q2, the fastest rate in years, driven by aerospace and defense and semiconductor volumes.
The Q1 FY2026 flag on Performance Materials recovery: the 's results are not broken out in this filing's narrative, but the consolidated improvement to 34% suggests the $3.5 million in incremental quality-issue costs flagged in Q1 did not recur at the same scale.
The FY2025 flag on recovery from 17.3% : GAAP gross margin reached 17.0% in Q2, up from 14.9% in Q1, and value-added gross margin hit 34%, the highest in the available quarterly record, indicating the $25.7 million quality-issue charge has annualized and margins are expanding beyond prior peaks.
The FY2025 flag on debt reduction: rose to $423.2 million from $405.7 million a year ago, and the $100 million plan for 2026 means debt paydown is not the current priority.
The Q1 FY2026 flag on Electronic Materials margin sustainability: the 's margin gains appear to be holding, as the 34% value-added was driven in part by favorable product mix in that segment.
What to watch
growth sustainability: whether the 15% rate can be maintained or accelerates further, or if Q2 represents a one-time increase from pent-up aerospace and defense and semiconductor demand.
on : whether the 34% level can be sustained now that mix benefits and beryllium hydroxide sales have lifted it to a multi-year high, or if it reverts toward the 31-33% range.
and the $100 million plan: with six-month at $70.5 million and full-year capex expected at $100 million, whether the company can fund the step-up in investment without increasing the $423.2 million in .
Performance Materials quality-issue resolution: whether the has fully moved past the $25.7 million charge from 2025 and the $3.5 million in incremental costs from Q1, or if operational disruption lingers.
, which exclude , grew 15% to $308.2M, led by volume gains in aerospace & defense (39%) and semiconductor (23%) end markets.
as a percentage of improved to 34% from 31%, driven by favorable product mix, manufacturing efficiencies, and higher beryllium hydroxide sales.
SG&A expense rose 21% to $42.3M due to higher incentive compensation accruals, while R&D expense remained flat at 2% of .
for the first six months was $70.5M, up from $65.4M, supported by management, with $232.7M in available borrowing capacity as of quarter-end.
The company expects full-year 2026 of approximately $100M and believes current liquidity is adequate to support operations and strategic initiatives.
Quantitative and Qualitative Disclosures About Market Risk
For information regarding market risks, refer to Item 7A. Quantitative and Qualitative Disclosures About Market Risk in our 2025 Annual Report on Form 10-K. There have been no material changes in our market risks since the inclusion of this discussion in our 2025 Annual Report o…
⌄
For information regarding market risks, refer to Item 7A. Quantitative and Qualitative Disclosures About Market Risk in our 2025 Annual Report on Form 10-K. There have been no material changes in our market risks since the inclusion of this discussion in our 2025 Annual Report on Form 10-K.
39
Our subsidiaries and our holding company are subject, from time to time, to a variety of civil and administrative proceedings arising out of our normal operations, including, without limitation, product liability claims, health, safety, and environmental claims, and employment-r…
⌄
Our subsidiaries and our holding company are subject, from time to time, to a variety of civil and administrative proceedings arising out of our normal operations, including, without limitation, product liability claims, health, safety, and environmental claims, and employment-related actions.
The information presented in the Legal Proceedings section of Note P ("Contingencies") of the Notes to Consolidated Financial Statements (Unaudited) is incorporated herein by reference.